Freya Biosciences License ApS: Financial statements 2021
CVR: 41372079
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Freya Biosciences License ApS (CVR 41372079) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -37,500 and a net result of DKK -37,500. Equity in the 2021 report amounted to DKK 19,456. The solvency ratio was 52.6%.
- Revenue
- DKK 0
- Gross Profit
- DKK -37,500
- Profit/Loss
- DKK -37,500
- Equity
- DKK 19,456
- Total Assets
- DKK 36,956
Official annual report
Find more companies like Freya Biosciences License ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Freya Biosciences License ApS has published its interim report for the period May 19, 2020 to December 31, 2020.
About Freya Biosciences License ApS
Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.
